DK0769942T3 - Anvendelse af en kationisk amfipatisk forbindelse som transfektionsmiddel, vaccineadjuvans eller medikament - Google Patents
Anvendelse af en kationisk amfipatisk forbindelse som transfektionsmiddel, vaccineadjuvans eller medikamentInfo
- Publication number
- DK0769942T3 DK0769942T3 DK96913569T DK96913569T DK0769942T3 DK 0769942 T3 DK0769942 T3 DK 0769942T3 DK 96913569 T DK96913569 T DK 96913569T DK 96913569 T DK96913569 T DK 96913569T DK 0769942 T3 DK0769942 T3 DK 0769942T3
- Authority
- DK
- Denmark
- Prior art keywords
- opt
- unsatd
- transfection agent
- drug
- cationic amphipathic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
- A61K48/0025—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/812—Liposome comprising an antibody, antibody fragment, antigen, or other specific or nonspecific immunoeffector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9504615A FR2732895B1 (fr) | 1995-04-11 | 1995-04-11 | Utilisation d'un compose amphipathique cationique comme agent de transfection, comme adjuvant de vaccin, ou comme medicament |
PCT/FR1996/000547 WO1996032102A1 (fr) | 1995-04-11 | 1996-04-11 | Utilisation d'un compose amphipathique cationique comme agent de transfection, comme adjuvant de vaccin, ou comme medicament |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0769942T3 true DK0769942T3 (da) | 2003-01-06 |
Family
ID=9478207
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK96913569T DK0769942T3 (da) | 1995-04-11 | 1996-04-11 | Anvendelse af en kationisk amfipatisk forbindelse som transfektionsmiddel, vaccineadjuvans eller medikament |
Country Status (12)
Country | Link |
---|---|
US (1) | US6124270A (da) |
EP (2) | EP0769942B1 (da) |
JP (1) | JPH10501822A (da) |
AT (1) | ATE223716T1 (da) |
AU (1) | AU704369C (da) |
CA (1) | CA2192597A1 (da) |
DE (1) | DE69623559T2 (da) |
DK (1) | DK0769942T3 (da) |
ES (1) | ES2181885T3 (da) |
FR (1) | FR2732895B1 (da) |
PT (1) | PT769942E (da) |
WO (1) | WO1996032102A1 (da) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2726764B1 (fr) * | 1994-11-14 | 1997-01-31 | Pasteur Merieux Serums Vacc | Adjuvant pour composition vaccinale |
US6331524B1 (en) | 1994-12-09 | 2001-12-18 | Genzyme Corporation | Organ-specific targeting of cationic amphiphile / DNA complexes for gene therapy |
US5939401A (en) * | 1994-12-09 | 1999-08-17 | Genzyme Corporation | Cationic amphiphile compositions for intracellular delivery of therapeutic molecules |
US5948767A (en) * | 1994-12-09 | 1999-09-07 | Genzyme Corporation | Cationic amphiphile/DNA complexes |
US6383814B1 (en) | 1994-12-09 | 2002-05-07 | Genzyme Corporation | Cationic amphiphiles for intracellular delivery of therapeutic molecules |
AUPN741696A0 (en) * | 1996-01-05 | 1996-01-25 | Commonwealth Scientific And Industrial Research Organisation | Delivery of nucleic acids ii |
JP3910646B2 (ja) | 1997-04-07 | 2007-04-25 | 第一製薬株式会社 | 「細胞への遺伝子導入用組成物」 |
FR2763958A1 (fr) | 1997-05-29 | 1998-12-04 | Transgene Sa | Produit de combinaison associant un acide nucleique a une substance desorganisant la matrice extracellulaire pour la therapie genique |
US6372720B1 (en) | 1998-02-05 | 2002-04-16 | Kenneth J. Longmuir | Liposome fusion and delivery vehicle |
FR2781160B1 (fr) * | 1998-07-03 | 2000-08-18 | Pasteur Merieux Serums Vacc | Utilisation d'un compose amphipathique pour adjuver un vaccin sous-unitaire |
FR2814958B1 (fr) * | 2000-10-06 | 2003-03-07 | Aventis Pasteur | Composition vaccinale |
CA2469491A1 (en) * | 2001-12-12 | 2003-06-19 | Kerrie Setiawan | Composition for viral preservation |
US20060211004A1 (en) | 2005-02-15 | 2006-09-21 | Ilsley Diane D | Methods and compositions for determining non-specific cytotoxicity of a transfection agent |
EP1938843A1 (en) * | 2006-12-19 | 2008-07-02 | Novosom AG | Lipids and lipid assemblies comrising transfection enhancer elements |
US8877206B2 (en) * | 2007-03-22 | 2014-11-04 | Pds Biotechnology Corporation | Stimulation of an immune response by cationic lipids |
CN106310293A (zh) * | 2007-09-27 | 2017-01-11 | 免疫疫苗技术有限公司 | 在包括连续疏水相的载体中的脂质体在体内输送多核苷酸中的应用 |
US20100209452A1 (en) * | 2007-10-03 | 2010-08-19 | Immunovaccine Technologies, Inc | Compositions comprising an antigen, an amphipathic compound and a hydrophobic carrier, and uses thereof |
CN102137675A (zh) | 2008-04-17 | 2011-07-27 | Pds生物科技公司 | 通过阳离子脂质的对映体刺激免疫应答 |
EP2296696B1 (en) | 2008-06-05 | 2014-08-27 | ImmunoVaccine Technologies Inc. | Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance |
CN113876945A (zh) | 2011-10-06 | 2022-01-04 | 免疫疫苗技术有限公司 | 包括激活或增加tlr2活性的佐剂的脂质体组合物及其应用 |
US20150250872A1 (en) | 2012-09-21 | 2015-09-10 | Frank Bedu-Addo | Vaccine compositions and methods of use |
GB201315321D0 (en) | 2013-08-28 | 2013-10-09 | Koninklijke Nederlandse Akademie Van Wetenschappen | Transduction Buffer |
EP3275448A4 (en) * | 2015-03-24 | 2019-05-01 | Kyowa Hakko Kirin Co., Ltd. | LIPID NANOPARTICLES CONTAINING NUCLEIC ACIDS |
US11612652B2 (en) | 2015-11-13 | 2023-03-28 | Pds Biotechnology Corporation | Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dendritic cell therapy |
JP7298850B2 (ja) * | 2018-03-27 | 2023-06-27 | 日油株式会社 | 細胞内動態を改善した新規カチオン性脂質 |
EP3646854B1 (en) * | 2018-10-30 | 2022-08-03 | PolyPlus Transfection | Compositions for transfecting mrna into a cell and their applications |
WO2021060440A1 (ja) * | 2019-09-26 | 2021-04-01 | 日油株式会社 | 脂質ナノ粒子の凍結乾燥組成物 |
WO2024018762A1 (ja) * | 2022-07-19 | 2024-01-25 | 国立大学法人北海道大学 | pH感受性カチオン性脂質及び脂質ナノ粒子 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3906092A (en) * | 1971-11-26 | 1975-09-16 | Merck & Co Inc | Stimulation of antibody response |
EP0152379A3 (de) * | 1984-02-15 | 1986-10-29 | Ciba-Geigy Ag | Verfahren zur Herstellung von pharmazeutischen Zusammensetzungen enthaltend unilamellare Liposomen |
US4897355A (en) * | 1985-01-07 | 1990-01-30 | Syntex (U.S.A.) Inc. | N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
US5283185A (en) * | 1991-08-28 | 1994-02-01 | University Of Tennessee Research Corporation | Method for delivering nucleic acids into cells |
US5858784A (en) * | 1991-12-17 | 1999-01-12 | The Regents Of The University Of California | Expression of cloned genes in the lung by aerosol- and liposome-based delivery |
CA2135313A1 (en) * | 1992-06-18 | 1994-01-06 | Theodore Choi | Methods for producing transgenic non-human animals harboring a yeast artificial chromosome |
AUPM747694A0 (en) * | 1994-08-16 | 1994-09-08 | Commonwealth Scientific And Industrial Research Organisation | Delivery of nucleic acids and peptides |
US5736524A (en) * | 1994-11-14 | 1998-04-07 | Merck & Co.,. Inc. | Polynucleotide tuberculosis vaccine |
-
1995
- 1995-04-11 FR FR9504615A patent/FR2732895B1/fr not_active Expired - Fee Related
-
1996
- 1996-04-11 CA CA002192597A patent/CA2192597A1/fr not_active Abandoned
- 1996-04-11 AU AU56517/96A patent/AU704369C/en not_active Ceased
- 1996-04-11 AT AT96913569T patent/ATE223716T1/de not_active IP Right Cessation
- 1996-04-11 EP EP96913569A patent/EP0769942B1/fr not_active Expired - Lifetime
- 1996-04-11 JP JP8530772A patent/JPH10501822A/ja active Pending
- 1996-04-11 DK DK96913569T patent/DK0769942T3/da active
- 1996-04-11 WO PCT/FR1996/000547 patent/WO1996032102A1/fr active IP Right Grant
- 1996-04-11 US US08/750,503 patent/US6124270A/en not_active Expired - Fee Related
- 1996-04-11 ES ES96913569T patent/ES2181885T3/es not_active Expired - Lifetime
- 1996-04-11 DE DE69623559T patent/DE69623559T2/de not_active Expired - Fee Related
- 1996-04-11 EP EP02014143A patent/EP1245249A3/fr not_active Withdrawn
- 1996-04-11 PT PT96913569T patent/PT769942E/pt unknown
Also Published As
Publication number | Publication date |
---|---|
DE69623559T2 (de) | 2003-08-07 |
PT769942E (pt) | 2003-01-31 |
WO1996032102A1 (fr) | 1996-10-17 |
ATE223716T1 (de) | 2002-09-15 |
FR2732895A1 (fr) | 1996-10-18 |
AU704369B2 (en) | 1999-04-22 |
AU5651796A (en) | 1996-10-30 |
EP0769942A1 (fr) | 1997-05-02 |
AU704369C (en) | 2004-03-11 |
CA2192597A1 (fr) | 1996-10-17 |
EP1245249A2 (fr) | 2002-10-02 |
EP1245249A3 (fr) | 2002-12-11 |
EP0769942B1 (fr) | 2002-09-11 |
JPH10501822A (ja) | 1998-02-17 |
US6124270A (en) | 2000-09-26 |
DE69623559D1 (de) | 2002-10-17 |
ES2181885T3 (es) | 2003-03-01 |
FR2732895B1 (fr) | 1997-05-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0769942T3 (da) | Anvendelse af en kationisk amfipatisk forbindelse som transfektionsmiddel, vaccineadjuvans eller medikament | |
DK385387D0 (da) | Amidderivater | |
ES2061465T3 (es) | Derivados de oxadiazolilalquilpurina, su preparacion y su aplicacion en productos farmaceuticos. | |
FI945581A (fi) | Substituoidut (aryylialkoksibentsyyli) aminopropaaniamidijohdannaiset, niiden valmistus ja käyttö antiepileptisinä, neuroprotektiivisina ja antidepressiivisinä aineina | |
DE68921719D1 (de) | Amphotericin B Derivate. | |
FI945582A0 (fi) | Substituoidut (aryylialkyyliaminobentsyyli) aminopropioniamidijohdannaiset, niiden valmistus ja käyttö anti-epileptisinä, neuroprotektiivisina ja antidepressiivisina aineina | |
ES534859A0 (es) | Procedimiento para la obtencion de derivados de 1-(4'-alquilsulfonilfenil)-2-amino-1,3-propandiol n-substituidos | |
SE8302345L (sv) | Pleuromutilinderivat, forfaranden for deras framstellning och deras anvendning som lekemedel | |
ES8603415A1 (es) | Un procedimiento para preparar derivados de dihidropiridina | |
DE3466981D1 (de) | 1-(4'-alkylthiophenyl)-2-amino-1,3-propanediol n-substituted derivatives | |
ES2065192T3 (es) | Nuevos nicotinatos de diacil-glicerol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
ES2027492A6 (es) | Procedimiento de preparacion de nuevos derivados dihidropirimidotiazinos y de sus sales de adicion acidas farmaceuticamente aceptables. | |
NO893223L (no) | Blanding av organiske ammoniumsalter og deres anvendelse som stroemningsfremskyndere. |